Simplex Trading’s BioCardia BCDA Stock Holding History

Simplex Trading’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-260	Closed	-$1K	–	8758
2023 Q3	$1K	Sell	260 -493	-65%	-$8.29K	﹤0.01%	8246
2023 Q2	$30K	Sell	753 -1,347	-64%	-$41.5K	﹤0.01%	6341
2023 Q1	$61K	Buy	2,100 +300	+17%	+$9.96K	﹤0.01%	5696
2022 Q4	$56K	Buy	1,800 +867	+93%	+$24.7K	﹤0.01%	5722
2022 Q3	$27K	Buy	933 +733	+367%	+$19K	﹤0.01%	7176
2022 Q2	$4K	Sell	200 -400	-67%	-$9.58K	﹤0.01%	8929
2022 Q1	$18K	Buy	600 +140	+30%	+$4.16K	﹤0.01%	8340
2021 Q4	$13K	Sell	460 -493	-52%	-$18.1K	﹤0.01%	8794
2021 Q3	$55K	Hold	953	–	–	﹤0.01%	7405
2021 Q2	$56K	Buy	953 +928	+3,712%	+$56.3K	﹤0.01%	7502
2021 Q1	$162K	Buy	+25	New	+$1.56K	﹤0.01%	5060

Other funds holding BCDA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's BCDA Position: Q2 2024 in Review

Simplex Trading sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 480 shares — an estimated $2K sold.

Simplex Trading first reported a position in BCDA in Q1 2021 and held it in 10 quarters. The position peaked at $100K in Q1 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

Simplex Trading reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 480 BioCardia shares in Q2 2024, an estimated $2K.
Simplex Trading first reported a position in BioCardia in Q1 2021 and held it in 10 quarters.
Simplex Trading's BioCardia position peaked at $100K in Q1 2021.
10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.